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Abstract
Background: Post-occlusive hyperemia is often used as a paradigm to evaluate vascular reactivity, for example by
measuring post-ischemic flow-mediated dilation, arterial blood flow or temporally resolved venous blood
oxygenation (HbO2). Here we demonstrate the feasibility of a simultaneous measurement of blood flow and HbO2
in the femoral circulation as part of a single procedure.
Methods: A multi-echo GRE pulse sequence was designed and implemented to collect velocity-encoded
projections in addition to full-image echoes for field mapping as a means to quantify intravascular magnetic
susceptibility. The method’s feasibility was evaluated at 3T in a small pilot study involving two groups of healthy
subjects (mean ages 26 ± 1.6 and 59 ± 7.3 years, N = 7 and 5, respectively) in terms of six parameters
characterizing the time-course of reactive hyperemia and their sensitivity to differentiate age effects. The
reproducibility was assessed on two of the seven young healthy subjects with three repeated measurements.
Results: The physiological parameters agree with those obtained with current methods that quantify either
velocity or HbO2 alone. Of the six measures of vascular reactivity, one from each group was significantly different
in the two subject groups (p < 0.05) even though the study was not powered to detect differences. The mean
coefficient of variation (CV) from two subjects undergoing repeat scans were approximately 8% for the oximetric
and the arterial velocimetric parameters in the femoral vein and artery, respectively, considerably below
intersubject CVs (20 and 35%, for the young and older subject groups, respectively).
Conclusion: The proposed method is able quantify multiple parameters that may lead to more detailed
assessment of peripheral vascular reactivity in a single cuff paradigm rather than in separate procedures as required
previously, thereby improving measurement efficiency and patient comfort.
Background
In the United States, cardiovascular diseases (CVD)
account for more deaths than cancers, chronic obstruc-
tive pulmonary diseases and accidents combined [1].
T h eb u r d e no fC V Di nt h ef u t u r ei se x p e c t e dt og r o w
due to the aging population, prevalence of obesity [2,3]
and unhealthy lifestyle choices that include smoking [4],
lack of physical activity [5] and poor nutrition [6,7]; all
factors predisposing subjects to develop systemic athero-
sclerosis that can remain silent for decades. The earliest
stage of pathogenesis of atherosclerosis, the most
common cause of CVD, is endothelial dysfunction
(EDF), which can manifest as impaired reactivity in the
peripheral vascular bed (e.g. brachial or femoral arteries)
due to the suppression of nitric oxide (NO) [8] synth-
esis. In normal vascular function greater demand for
blood flow in response to a physiological challenge is
accommodated initially via reduction of microvascular
resistance. Subsequently, increase in shear stress to the
vessel wall promotes NO release resulting in vasodila-
tion (referred to as flow-mediated dilation (FMD)) of
the conduit artery [9]. Thus, micro- and macrovascular
function can be assessed during reactive hyperemia.
Among non-invasive imaging modalities used to quan-
tify reactive hyperemia in peripheral arteries are near-
infrared spectroscopy (NIRS) [10-13], single photon
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magnetic resonance (CMR) [15-18], and ultrasound [19].
NIRS and ultrasound (US) are most commonly used
due to their portability. NIRS is relatively inexpensive,
has excellent temporal resolution and is less prone to
artifacts from subject motion. It also allows simulta-
neous monitoring of relative changes in tissue blood
flow and oxygenation [12]. However, the method’ss p a -
tial resolution is limited and can only provide microvas-
cular function in relatively superficial tissues. In
addition, the tissue response to light depends on skin
color, body fat and muscle layers, leading to large inter-
subject variations [20]. US measurements of FMD in the
brachial artery have generated substantial interest in
clinical research since its introduction [21]. Numerous
studies have since demonstrated the prognostic value of
brachial artery FMD [22,23]. However, the methodology
suffers from substantial inter- and intra-observer varia-
bility [9,24] in that probe placement or US settings such
as dynamic range, gain and probe distance can signifi-
cantly affect diameter measurements [25]. These sources
of error are of particular concern since the average rela-
tive change of FMD is on the order of 5% only [26].
CMR has also demonstrated its potential for evaluat-
ing vascular reactivity. CMR flow velocimetry can be
performed with high spatial and temporal resolution as
demonstrated in a recent study in which post-occlu-
sion hyperemia in the femoral artery was evaluated in
PAD patients and healthy subjects 1.5 T [16]. The
implementation of the method requires spatially-selec-
tive rf pulses which are not widely available and migra-
tion to systems with higher field strength may be
challenging due to increased field inhomogeneity.
Alternatively, microvascular function can be assessed
by quantifying post-occlusive perfusion with arterial
spin labeling (ASL) [17] in calf muscle. The ASL-
approach is model-dependent and the temporal resolu-
tion is limited.
All of the above methods only target one aspect of the
vascular reactivity, e.g. hemodynamics, tissue oxygena-
t i o n ,o rF M D ,a sp o s s i b l ei n d icators of endothelial dys-
function. We posit that quantification of several
physiological parameters may lead to a more sensitive
assessment for detecting early stage of EDF. As a step
toward an integrated CMR protocol to detect early
stages of EDF and to extend a MR procedure developed
previously based on using oxygen saturation as a
dynamic tracer [18], we describe an interleaved multi-
echo gradient-recalled (GRE) sequence that is able of
temporally resolve venous blood oxygen saturation and
flow velocity simultaneously during hyperemia. The fea-
sibility and reproducibility of the proposed method is
demonstrated in seven young and five older healthy
subjects.
Methods
Integration of MR susceptometry and projection-based
velocity quantification
MR susceptometry relies on the quantification of the
HbO2-dependent susceptibility difference between intra-
vascular blood and surrounding tissue [27,28]. For the
remainder of the manuscript HbO2 is defined as the
fractional oxygen saturation expressed in percent. The
relative susceptibility difference can be derived from a
phase difference image between two gradient echoes dif-
fering in echo time. Velocity is computed from a phase
difference image between interleaved GREs differing in
velocity-encoding. The basic idea of integrating MR sus-
ceptometry and velocity quantification is to interleave
multi-echo GREs with different velocity encoding [27].
However, in order to achieve adequate temporal resolu-
tion to map the time-course of hyperemia, the velocity
will be quantified with projections [29] while full 2D
echoes will be acquired for HbO2 quantification.
Pulse Sequence
The pulse sequence for temporally-resolved measure-
ment of venous oxygen saturation and flow velocity is
shown in Figure 1a. It consists of a fat-suppressed
multi-echo GRE pulse sequence for collecting velocity-
encoded projections sampled at TE1 (i.e. in the absence
of phase-encoding). The same excitation generates two
additional echoes (TE2 and TE4), which are phase-
encoded, thereby yielding a full image for field mapping.
The velocity encoding is toggled after each TR by separ-
ating the flow-compensating gradient lobes appropri-
ately (dashed box Figure 1a); the maximum temporal
resolution is 2 × TR. Thus, while the pulse sequence
collects velocity-encoded projections at TE1 the phase-
encoding gradient is incremented for the remaining
echoes. In this manner, 64 pairs of velocity-encoded
projections can be collected while a single 2D field map
is obtained from TE2 and TE4. The sequence in Figure
1b collects a 2D reference image at TE1 for removing
background tissue signal from the velocity-encoded pro-
jections, as explained in more detail below. In addition,
data are acquired at TE2 and TE4 for 2D field mapping.
In this manner, uninterrupted measurement of HbO2 is
ensured. We note that TE2 and TE4 have the same first
moment in all three directions so that flow-induced
phase accumulation is minimized for the field maps.
Subjects
Seven healthy young (YH, 26 ± 1.6 yrs) and five older
healthy (OH, 59 ± 7.3 yrs) subjects without prior history
of cardiovascular disease were recruited to evaluate the
performance of the interleaved pulse sequence in terms
of reproducibility and the potential to detect expected
age-related differences between the two groups with
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subjects were free of peripheral arterial disease the
ankle-brachial index (ABI) was determined. All subjects
evaluated had ABI > 0.9. Written informed consent was
obtained prior to all examinations following an institu-
tional review board-approved protocol.
Cuff paradigm
Ischemia was induced by inflating a blood pressure cuff
(Aspen Labs A.T.S 1500 Tourniquet System) to 75
mmHg above the systolic pressure in the upper thigh.
The location was chosen so as to minimize perturbation
of the imaging region (approximately 10 cm superior to
the knee) during cuff inflation or deflation. On ten sub-
jects (5 YH and 5 OH), the cuff paradigm consisting of
2 mins baseline, 5 mins occlusion and 6 mins recovery
was performed to monitor post-ischemic vascular
reactivity.
Reproducibility
Two YH subjects (not taken from the pool of 5 YH)
participated only in the reproducibility study where an
abbreviated cuff paradigm (3 mins occlusion and 2 mins
recovery) was used in order to allow for three repeated
measurements in a single session to assess reproducibil-
ity. After each scan the subject was removed from the
scanner and allowed to rest for 15 mins to ensure full
recovery before repeating cuff occlusion.
CMR Protocol
All imaging was performed on a 3T Siemens Trio.
Phased-array eight-channel knee coil (Invivo Inc.,
Pewaukee, WI) was used to acquire axial images of
femoral vessels. From the scout images an appropriate
readout direction was chosen to avoid overlap between
the femoral artery and vein along the projection direc-
tion. For the data acquisition the following imaging
parameters were used: TE/TR = 5.0/39.1 ms, flip angle
=1 3 ° ,B a n d w i d t h=5 2 0H z / p i x ,v o x e ls i z e=1×1×5
mm
3, matrix size = 128 × 128. In addition to acquiring
velocity-encoded projections taken with equal magni-
tude but opposite-sign first moments, flow-compensated
projections (not shown in Figure 1) were also acquired
repeatedly to ensure acquisition of unaliased phase data.
Thus, three projections offer the flexibility of achieving
either VENC of 125 or 250 cm/s, as needed, i.e. by com-
puting the phase difference between acquisitions taken
with opposite polarity flow-encoding gradients or
between zero and non-zero first-moment encoded pro-
jections. The pulse sequence of Figure 1a was launched
10 s prior to and was run for 60 s after the cuff release.
For the remaining recovery period only HbO2 was mon-
itored with the flow-compensated pulse sequence (Fig-
ure 1b). The pulse sequence achieves temporal
resolutions of 5 s and 117 ms for dynamic oximetry and
velocity quantification, respectively.
Data Analysis
HbO2 quantification
The raw k-space data were processed off-line. A phase
difference image was computed with the images of
equal polarity echoes, e.g. TE2 and TE4. The effects of
low spatial-frequency modulations of static magnetic
field were minimized by fitting the data, after appropri-
ate weighting and masking, to a second-order polyno-
mial [30]. The hemoglobin oxygen saturation, HbO2,i n
a b
TE1 TE2 TE4
RF
Gz
Gy
Gx
TE1 TE2 TE4
Figure 1 Multi-echo GRE pulse sequence to a) collect velocity-encoded projections (TE1) and full-image echoes. b) Full image is
collected at TE1 (note phase encodes are repositioned) for removing tissue signal from the projections. The first RF pulse, followed by a spoiler
gradient, is for lipid suppression.
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HbO2 =

1 −
6 |  φ | / TE
γ χ doHct · Bo(3cos2θ − 1)

[1].
where Δj is the average intravascular phase relative to
surrounding tissue, ΔTE = TE4 - TE2, is the inter-echo,
g is the gyromagnetic ratio of water protons, Δcdo =4 π
×( 0 . 2 7±0 . 0 2 ) ppm [31] is the susceptibility difference
between fully deoxygenated and fully oxygenated ery-
throcytes in SI units, θ is the vessel tilt angle relative to
the main field Bo and Hct (hematocrit) is the volume
fraction of erythrocytes in packed blood.
The time-course of HbO2 characterize vascular reac-
tivity with three parameters: washout time, upslope and
overshoot, as described previously [18]. The washout
time refers to the elapsed time to observe oxygen-
depleted capillary blood at the measurement location
after cuff deflation (t = 0). Resaturation occurs at a
mean rate termed upslope and the transient increase in
blood flow rate leads to an overshoot, an above-baseline
HbO2 level.
Blood velocity quantification
In order to isolate the vascular signal from static tissue a
projection derived from the reference image is sub-
tracted from the velocity-encoded projections as
described previously [29]. In brief, the vessels of interest
are masked out manually from the complex reference
image and then Fourier transformed to k-space. The
projection, which contains tissue signal only, is then
subtracted from the velocity-encoded projections, thus
isolating blood signal. The subtraction is performed in
the complex domain to retain the phase information.
The phase differences between velocity-encoded projec-
tions are converted to velocity using the relation
between phase j and velocity v,a sν = j·VENC/π.T h e
spatially averaged velocities of the vessels of interest are
d e r i v e db ya v e r a g i n gt h ev e l o c i t ya l o n gt h er e a d o u t
direction within the vessel boundaries. Thus, at each
temporal point, the average velocity represents the velo-
city averaged over the lumen.
The following parameters are derived from the time-
resolved blood flow velocity: time required to reach
peak average velocity (time-to-peak (TTP)), the duration
of forward flow (Tff)a n dmaximum change in the flow
rate relative to baseline (ΔQmax), which we define as the
ratio, vpeak, avg/vbase, avg. The parameter vbase, avg is com-
puted by averaging the time-resolved velocity over 6 - 8
cardiac cycles and vpeak, avg is the peak of the temporally
averaged velocity via 2-second sliding window during
the course of hyperemia. Computation of ΔQmax ignores
the very small change in lumen area that is not detect-
able at the resolution of 1 mm. This leads to an error
no greater than 5% based on previous observations
[16,32] where the lumen diameter was found to increase
by 3-5% during peak hyperemia.
Results
Representative magnitude and phase difference images
of the femoral artery and vein are shown in Figure 2.
The phase difference image (Figure 2b) demonstrates
the susceptibility-induced phase contrast between vein
and artery. Figure 2c more clearly shows that the rela-
tive difference in the magnetic susceptibility is negligible
between tissue and fully oxygenated arterial blood. The
temporal position of HbO2 time-course in femoral vein
(Figure 2d) is defined with respect to the acquisition
time of the center of k-space, e.g. 2.5 s, 7.5 s, 12.5 s etc.
According to error propagation (eqn. 1) the predomi-
nant contributor to standard error of HbO2 is the error
in Δj; conservatively estimated at ± 3%HbO2.D u r i n g
baseline the blood oxygen saturation level is approxi-
mately 67% (dashed horizontal line). In healthy subjects,
the observed blood oxygenation at the imaging slice
typically ranges from 30 to 85% post occlusion, repre-
senting the saturation level of washed-out oxygen-
depleted blood and maximum above-baseline value dur-
ing peak hyperemia, respectively. The range of HbO2
values qualitatively agrees with tissue HbO2 measure-
ments made with near-infrared spectroscopy [12]. Fig-
ure 3 shows time-resolved velocity data derived from
projection images of the femoral artery. Figure 3a dis-
plays time series of projection images, Figure 3b the
time-course of velocity during hyperemia (expanded in
Figure 3c). The latter highlights the sharp increase in
the averaged blood flow velocity and monophasic
+S S
0
-S S
abc
Washout time
Upslope
Overshoot
HbO2,baseline
d
Figure 2 a) Sample magnitude and b) phase difference image
for quantifying venous HbO2 in the femoral vein of a healthy
young subject. The region in the dashed box is magnified in panel
c). d) Representative time-course of HbO2.
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phase of hyperemia, presumably due to reduced micro-
vascular resistance. The velocity waveforms as well as
the typical peak average velocity agree with previous
MR quantifications [15,33]. The results are summarized
in Table 1 where the average value and standard devia-
tion (SD) for each parameter are reported for each
group. Uncertainty (determined via error propagation)
for each parameter is also included under each column
heading. Based on a two-tailed t-test, assuming unequal
variances, overshoot and TTP were significantly differ-
ent (p < 0.05) between YH and OH subjects. We also
observe that the standard deviations of the parameters
(all but the overshoot) are greater among the OH,
which may reflect longer exposure to different types of
lifestyles.
Table 1 Summary of physiological parameters derived from dynamic oximetry and velocimetry.
Age
(yrs)
Washout
(± 2.5 sec)
Upslope
(± 0.2%HbO2/sec)
Overshoot
(± 3%HbO2)
ΔQmax
± 0.5
Tff
(± 1 sec)
TTP
(± 1 sec)
Old (59 ± 7.3 yrs)
58 27.5 0.49 2 3.8 28 20
55 22.5 0.78 7 10.4 25 16
56 12.5 1.9 7 8.3 30 16
55 17.5 0.9 10 13.8 15 14
72 17.5 1.3 10 5.9 26 17
59.2 ± 7.3 19.5 ± 5.7 1.07 ± 0.55 7.2 ± 3.3 8.44 ± 3.9 24.8 ± 5.8 16.6 ± 2.2
Young (26 ± 1.6 yrs)
25 17.5 1.2 13 9.2 22 14
26 17.5 1.8 25 12 25 14
26 12.5 1.8 30 12.5 30 11
25 12.5 1.9 25 7.7 20 11
29 12.5 1.9 20 6.65 25 14
26.2 ± 1.6 14.5 ± 2.7 1.72 ± 0.29 22.6 ± 6.4 9.61 ± 2.6 24.4 ± 3.8 12.8 ± 1.64
*p-value 0.127 0.058 0.003 0.592 0.9 0.017
*Two-tailed t-test assuming unequal variances.
+125 cm/s
0
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Figure 3 Post-occlusive blood flow velocity in the femoral artery in a 25 year-old male. a) Magnified view of a velocity image
reconstructed from velocity-encoded projections during the early phase of hyperemia after the cuff deflation (background cropped). The time
axis and the readout direction are indicated and each vertical line represents a velocity profile obtained from a pair of velocity-encoded
projections. b) time-course of blood flow velocity (region of red rectangle magnified in panel c). The duration of forward flow Tff is indicated by
the double arrow. The magnification in c) shows that each spike corresponds to a systolic peak.
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flow velocity (Figure 4b) are shown for one of the sub-
jects. The largest variations between scans in the HbO2
time-course typically occur just prior to cuff release due
to the absence of flow-related enhancement. However,
this is largely irrelevant since none of the parameters of
interest are affected by the pre-cuff-release signal course.
In Figure 4b the blood flow velocity was averaged over 2
s sliding-window intervals for comparing the velocity
time-courses of three measurements. The average oxi-
metric and velocimetric parameters from the three suc-
cessive scans along with their SD and coefficients of
variation (CV) are summarized in Table 2. For the repro-
ducibility study, the average blood flow velocity at rest
was not quantified (therefore ΔQmax could not be com-
puted). Instead, we report peak average velocity, vpeak, avg,
(Figure 4b). For both subjects the average CV is approxi-
mately 8% but the CV was as high as 16% (overshoot in
26 yr-old subject). However, it should be noted that the
intersubject SD is about 50% and thus much greater than
intrasubject SD (Table 1) for all parameters.
Discussion
The work shows that simultaneous measurement of
dynamic oximetric and arterial flow velocity is possible
for assessing post-occlusive peripheral vascular reactiv-
ity. In contrast, a sequential measurements would
require application of the cuff twice, which would not
be tolerable by a significant number of patients. The
method returns six parameters, three each related to the
time-course of venous HbO2, and arterial flow velocity.
The time-course of HbO2 (referred to as dynamic oxi-
metry) follows the fate of the oxygen-depleted blood in
the capillary bed upon restoration of flow and its subse-
quent replacement by normally oxygenated venous
blood. It thus provides quantitative information on how
rapidly oxygen-depleted blood is washed out of tissue as
well as the rate at which tissue is resaturated. In addi-
tion, the overshoot may reflect the magnitude of hypere-
mia since tissue has reduced time to extract O2, a time-
consuming process driven by perfusion, thus greater
above-baseline HbO2 is expected with more pronounced
hyperemia. The oximetric parameters derived in this
pilot study are consistent with those of the authors’
prior work in which a significantly greater overshoot
was observed in healthy young compared to older sub-
jects [18].
Table 2 Repeat measurements of reactive hyperemia in
two healthy subjects.
Washout
(sec)
Upslope
(HbO2/sec)
Overshoot
(HbO2)
Tff
(sec)
TTP
(sec)
vpeak, avg
(cm/s)
Healthy 39 yr-old
Exp 1 15 2 30 19 10 13.5
Exp 2 12.5 1.9 32 15 9 13.6
Exp 3 12.5 2.2 30 17 9 12.5
Avg 13.3 2.0 30.7 17 9.3 13.2
Std 1.4 0.15 1.15 2 0.58 0.61
CV (%) 10.5 7.5 3.7 11.8 6.2 4.6
Healthy 26 yr-old
Exp 1 22.5 1.32 11 10 4.1 20.6
Exp 2 22.5 1.29 8 12 4.4 24.6
Exp 3 22.5 1.54 10 12 4 25.4
Avg 22.5 1.38 9.7 11.3 4.17 23.5
Std 0 0.136 1.53 1.15 0.21 2.57
CV (%) 0 9.9 15.8 10.2 5.0 10.9
ab a b
Figure 4 Post-occlusive time-courses of a) HbO2 in femoral vein and b) average blood flow velocity in femoral artery after 3 mins of
cuff occlusion. The red arrow indicates time-to-peak (TTP), the temporal location of the peak temporally-averaged velocity over a 2-second
sliding window.
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tively agrees with previous “real-time” phase-contrast
CMR data [15,16] including the duration of forward
flow (TFF; 20 - 35 s) and peak average velocity (~ 40 -
60 cm/s). The unique feature of the “real-time” techni-
ques [15,16], including the current method, is the ability
to resolve the velocity waveform for each cardiac cycle
during hyperemia. In all cases, the blood flow direction
does not reverse during the early phase of hyperemia
(Figure 3b) due to significant reduction in microvascular
resistance. Since vasodilation is generally triggered by
NO release, TTP and Tff may assess the microvascular
function’s response to an ischemia, i.e. the rate and
maximum bioavailability of nitric oxide release.
The projection method has the usual limitation when
a spatial dimension is sacrificed for improved temporal
resolution in that velocity is resolved along a single spa-
tial direction only and thus inherently averaged along
the projected lumen. Hence, peak velocity cannot be
quantified but rather an average in the projection direc-
tion is extracted. Lastly, “misregistration” of femoral ves-
sels between reference image and projections during
hyperemia is largely avoided by applying the cuff 10 to
15 cm from the imaging slice, and since the blood velo-
city near the vessel wall is nearly zero the error in aver-
age velocity is expected to be small.
The proposed method is a component of an ongoing
development of CMR-based techniques for measuring
multiple parameters across different vascular territories
a sp a r to fas i n g l ee x a m i n a t i o nt os t u d ye n d o t h e l i a l
dysfunction.
Conclusions
The quantitative imaging method introduced provides a
series of parameters on peripheral vascular reactivity in
about fifteen minutes, allowing time for additional quan-
tification of physiological parameters in a single scan
session and should be of value to study preclinical cardi-
ovascular disease.
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